Thomas P Lodise (Thomas Lodise)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 51

Top Topics

Urinary Tract Infection

Staphylococcus Aureus

Top Venues

Pharmacotherapy

Open forum infectious diseases

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas P Lodise, Kevin W Garey, Jalal A Aram, Brian H Nathanson
Healthcare Resource Utilization and Discharge Readiness in Adult Hospitalized Patients With Candidemia or Invasive Candidiasis Who Received an Echinocandin: An Analysis of United States Hospitals. Open forum infectious diseases 11 (1) (2024)
Thomas P Lodise, Keith S Kaye, Anne Santerre Henriksen, Gunnar Kahlmeter
Review of the In Vitro Microbiological Activity of Mecillinam Against Common Uropathogens in Uncomplicated Urinary Tract Infection: Focus on Resistant Pathogens. Open forum infectious diseases 11 (6) (2024)
Thomas P Lodise, Sujata M Bhavnani, Paul G Ambrose, Helio S Sader, David R Andes, Jason M Pogue
Piperacillin/tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
David A Butler, Nimish Patel, J Nicholas O'Donnell, Thomas P Lodise
Combination therapy with IV fosfomycin for adult patients with serious Gram-negative infections: a review of the literature. The Journal of antimicrobial chemotherapy (2024)
Thomas P Lodise, Keith S Kaye, Anne Santerre Henriksen, Gunnar Kahlmeter
Review of the In Vitro Microbiological Activity of Mecillinam Against Common Uropathogens in Uncomplicated Urinary Tract Infection: Focus on Resistant Pathogens. Open forum infectious diseases 11 (6) (2024)
Thomas P Lodise, Engels N Obi, Alexandre H Watanabe, Emre Yucel, Jae Min, Brian H Nathanson
Comparative evaluation of early treatment with ceftolozane/tazobactam versus ceftazidime/avibactam for non-COVID-19 patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy (2024)
Thomas P Lodise, Kevin W Garey, Jalal A Aram, Brian H Nathanson
Healthcare Resource Utilization and Discharge Readiness in Adult Hospitalized Patients With Candidemia or Invasive Candidiasis Who Received an Echinocandin: An Analysis of United States Hospitals. Open forum infectious diseases 11 (1) (2024)
Thomas P Lodise, Keith S Kaye, Anne Santerre Henriksen, Gunnar Kahlmeter
Review of the In Vitro Microbiological Activity of Mecillinam Against Common Uropathogens in Uncomplicated Urinary Tract Infection: Focus on Resistant Pathogens. Open forum infectious diseases 11 (6) (2024)
Lisa T Hong, Kevin James Downes, Alireza FakhriRavari, Jacinda C Abdul-Mutakabbir, Joseph L Kuti, Sarah C J Jorgensen, David C Young, Mohammad H Alshaer, Matteo Bassetti, Robert A Bonomo, Mark Gilchrist, Soo Min Jang, Thomas P Lodise, Jason Alexander Roberts, Thomas Tängdén, Athena Zuppa, Marc H Scheetz
International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists. Pharmacotherapy 43 (8) (2023)
Laura Puzniak, Ryan Dillon, Thomas P Lodise
Methods to appraise available evidence and adequacy of data from a systematic literature review to conduct a robust network meta-analysis of treatment options for patients with hospital-acquired or ventilator-associated bacterial pneumonia. PloS one 18 (1) (2023)
Lisa T Hong, Kevin James Downes, Alireza FakhriRavari, Jacinda C Abdul-Mutakabbir, Joseph L Kuti, Sarah C J Jorgensen, David C Young, Mohammad H Alshaer, Matteo Bassetti, Robert A Bonomo, Mark Gilchrist, Soo Min Jang, Thomas P Lodise, Jason Alexander Roberts, Thomas Tängdén, Athena Zuppa, Marc H Scheetz
International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summary. Pharmacotherapy 43 (8) (2023)
Nimish Patel, Allison Gorseth, Gina Belfiore, Nicholas Stornelli, Colleen Lowry, Thomas P Lodise
Fluoroquinolone-Associated Adverse Events of Interest among Hospitalized Veterans Affairs Patients with Community-Acquired Pneumonia Who Were Treated with a Fluoroquinolone: A Focus on Tendonitis, Clostridioides difficile Infection, and Aortic Aneurysm. Pharmacotherapy (2023)
Laura Puzniak, Ryan Dillon, Thomas P Lodise
Methods to appraise available evidence and adequacy of data from a systematic literature review to conduct a robust network meta-analysis of treatment options for patients with hospital-acquired or ventilator-associated bacterial pneumonia. PloS one 18 (1) (2023)
Laura Puzniak, Ryan Dillon, Thomas P Lodise
Methods to appraise available evidence and adequacy of data from a systematic literature review to conduct a robust network meta-analysis of treatment options for patients with hospital-acquired or ventilator-associated bacterial pneumonia. PloS one 18 (1) (2023)
Thomas P Lodise, Emre Yucel, Engels N Obi, Alexandre H Watanabe, Brian H Nathanson
Incidence of acute kidney injury (AKI) and its impact on patient outcomes among adult hospitalized patients with carbapenem-resistant Gram-negative infections who received targeted treatment with a newer β-lactam or β-lactam/β-lactamase inhibitor-, polymyxin- or aminoglycoside-containing regimen. The Journal of antimicrobial chemotherapy (2023)
Thomas P Lodise, Lie Hong Chen, Rong Wei, Theresa M Im, Richard Contreras, Katia J Bruxvoort, Mauricio Rodriguez, Larry Friedrich, Sarah C Robinson
Clinical Risk Scores to Predict Nonsusceptibility to Trimethoprim-Sulfamethoxazole, Fluoroquinolone, Nitrofurantoin, and Third-Generation Cephalosporin Among Adult Outpatient Episodes of Complicated Urinary Tract Infection. Open forum infectious diseases 10 (8) (2023)
Laura Puzniak, Ryan Dillon, Thomas P Lodise
Methods to appraise available evidence and adequacy of data from a systematic literature review to conduct a robust network meta-analysis of treatment options for patients with hospital-acquired or ventilator-associated bacterial pneumonia. PloS one 18 (1) (2023)
Laura Puzniak, Ryan Dillon, Thomas P Lodise
Methods to appraise available evidence and adequacy of data from a systematic literature review to conduct a robust network meta-analysis of treatment options for patients with hospital-acquired or ventilator-associated bacterial pneumonia. PloS one 18 (1) (2023)
Timothy J Straub, Mary-Jane Lombardo, Jessica A Bryant, Liyang Diao, Thomas P Lodise, Daniel E Freedberg, Jennifer Wortman, Kevin D Litcofsky, Brooke R Hasson, Barbara H McGovern, Christopher B Ford, Matthew R Henn
Impact of a purified microbiome therapeutic on abundance of antimicrobial resistance genes in patients with recurrent Clostridioides difficile infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Thomas P Lodise, J Nicholas O'Donnell, Shruti M Raja, Jeffrey T Guptill, Smitha Zaharoff, Nyssa Schwager, Vance G Fowler, Tatiana Beresnev, Alison Wall, Katherine Wiegand, Elisavet Serti, Stephen Balevic, Henry F Chambers, null null
Safety of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase I, Open-Label Study in Healthy Adult Volunteers. Antimicrobial agents and chemotherapy (2022)
J Nicholas O'Donnell, Thomas P Lodise
New Perspectives on Antimicrobial Agents: Imipenem-Relebactam. Antimicrobial agents and chemotherapy 66 (7) (2022)
Gina A Suh, Thomas P Lodise, Pranita D Tamma, Jane M Knisely, Jose Alexander, Saima Aslam, Karen D Barton, Erica Bizzell, Katherine M C Totten, Joseph L Campbell, Benjamin K Chan, Scott A Cunningham, Katherine E Goodman, Kerryl E Greenwood-Quaintance, Anthony D Harris, Shayla E Hesse, Anthony Maresso, Veronique Nussenblatt, David T Pride, Michael Joseph Rybak, Zoe Sund, David Van Duin, Daria Van Tyne, Robin Patel, null null
Considerations for the Use of Phage Therapy in Clinical Practice. Antimicrobial agents and chemotherapy 66 (3) (2022)
Nicholas Rebold, Thomas P Lodise, Michael Joseph Rybak
Panacea or oversimplification: Relating AUC and troughs. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 79 (12) (2022)
Thomas P Lodise, Marc H Scheetz, Joseph J Carreno, Henry Chambers, Vance Fowler, Thomas L Holland
Associations Between Vancomycin Exposure and Acute Kidney Injury Within the Recommended Area Under the Curve Therapeutic Exposure Range Among Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections. Open forum infectious diseases 9 (2) (2022)
Thomas P Lodise, Janna Manjelievskaia, Elizabeth Hoit Marchlewicz, Mauricio Rodriguez
Retrospective Cohort Study of the 12-Month Epidemiology, Treatment Patterns, Outcomes, and Health Care Costs Among Adult Patients With Complicated Urinary Tract Infections. Open forum infectious diseases 9 (7) (2022)
Nicholas A Turner, Allan Xu, Smitha Zaharoff, Thomas L Holland, Thomas P Lodise
Determination of plasma protein binding of dalbavancin. The Journal of antimicrobial chemotherapy 77 (7) (2022)
Thomas P Lodise, J Nicholas O'Donnell, Stephen Balevic, Xing Liu, Kenan Gu, Jomy George, Shruti M Raja, Jeffrey T Guptill, Smitha Zaharoff, Nyssa Schwager, Vance G Fowler, Alison Wall, Katherine Wiegand, Henry F Chambers, null null
Pharmacokinetics of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase 1, Open-Label Study of Healthy Adults. Antimicrobial agents and chemotherapy (2022)
Thomas P Lodise, Teena Chopra, Brian H Nathanson, Katherine Sulham, Mauricio Rodriguez
Epidemiology of Complicated Urinary Tract Infections due to Enterobacterales Among Adult Patients Presenting in Emergency Departments Across the United States. Open forum infectious diseases 9 (7) (2022)
Monique R Bidell, Athena L V Hobbs, Thomas P Lodise
Gut microbiome health and dysbiosis: A clinical primer. Pharmacotherapy 42 (11) (2022)
Thomas P Lodise, Michael Nowak, Mauricio Rodriguez
The 30-Day Economic Burden of Newly Diagnosed Complicated Urinary Tract Infections in Medicare Fee-for-Service Patients Who Resided in the Community. Antibiotics (Basel, Switzerland) 11 (5) (2022)
Nicholas S Britt, Karim Khader, Tao He, Tina M Willson, Atim Effiong, Tristan T Timbrook, Emily M Potter, Thomas P Lodise
Examining the Clinical Impact of Rapid Multiplex Polymerase Chain Reaction-Based Diagnostic Testing for Bloodstream Infections in a National Cohort of the Veterans Health Administration. Pharmacotherapy (2022)
Thomas P Lodise, Ronald G Hall, Marc H Scheetz
Vancomycin Area Under the Curve-guided Dosing and Monitoring: "Is the Juice Worth the Squeeze"? Pharmacotherapy 40 (12) (2021)
Thomas P Lodise, Anne Santerre Henriksen, Thomas Hadley, Nimish Patel
US-Focused Conceptual Health Care Decision-Analytic Models Examining the Value of Pivmecillinam Relative to Current Standard-of-Care Agents Among Adult Patients With Uncomplicated Urinary Tract Infections due to Enterobacterales. Open forum infectious diseases 8 (10) (2021)
Thomas P Lodise, Scott Van Wart, Zoe M Sund, Adam M Bressler, Akram Khan, Amy T Makley, Yasir Hamad, Robert A Salata, Fernanda P Silveira, Matthew D Sims, Badih A Kabchi, Mohamed A Saad, Carrie Brown, Randolph E Oler, Vance Fowler, Richard G Wunderink
Pharmacokinetic and Pharmacodynamic Profiling of Minocycline for Injection following a Single Infusion in Critically Ill Adults in a Phase IV Open-Label Multicenter Study (ACUMIN). Antimicrobial agents and chemotherapy 65 (3) (2021)
J Nicholas O'Donnell, Vibert Putra, Thomas P Lodise
Treatment of patients with serious infections due to carbapenem-resistant Acinetobacter baumannii: How viable are the current options? Pharmacotherapy 41 (9) (2021)
Nimish Patel, Colleen Lowry, Daralyn Morgenson, Vaishali Shah, Nicholas Stornelli, Thomas P Lodise
Comparative effectiveness of early-targeted use of fidaxomicin versus oral vancomycin among hospitalized veterans' affairs patients with infections due to Clostridioides difficile. Pharmacotherapy 41 (2) (2021)
Monique R Bidell, Thomas P Lodise
Use of oral tetracyclines in the treatment of adult outpatients with skin and skin structure infections: Focus on doxycycline, minocycline, and omadacycline. Pharmacotherapy 41 (11) (2021)
Thomas P Lodise, Mauricio Rodriguez, Surya Chitra, Kelly Wright, Nimish Patel
Potential Cost Savings Associated with Targeted Substitution of Current Guideline-Concordant Inpatient Agents with Omadacycline for the Treatment of Adult Hospitalized Patients with Community-Acquired Bacterial Pneumonia at High Risk for Clostridioides difficile Infections: Results of Healthcare-Decision Analytic Model from the United States Hospital Perspective. Antibiotics (Basel, Switzerland) 10 (10) (2021)
Sean N Avedissian, Gwendolyn M Pais, Jiajun Liu, J Nicholas O'Donnell, Thomas P Lodise, Michael Neely, Walter C Prozialeck, Peter C Lamar, Leighton Becher, Marc H Scheetz
The Pharmacodynamic-Toxicodynamic Relationship of AUC and C max in Vancomycin-Induced Kidney Injury in an Animal Model. Antimicrobial agents and chemotherapy 65 (3) (2021)
Marc H Scheetz, Gwendolyn M Pais, Thomas P Lodise, Steven Y C Tong, Joshua S Davis, J Nicholas O'Donnell, Jiajun Liu, Michael Neely, Walter C Prozialeck, Peter C Lamar, Nathaniel James Rhodes, Thomas Holland, Sean N Avedissian
Of Rats and Men: a Translational Model To Understand Vancomycin Pharmacokinetic/Toxicodynamic Relationships. Antimicrobial agents and chemotherapy 65 (10) (2021)
Thomas P Lodise, Laura A Puzniak, Lie H Chen, Yun Tian, Rong Wei, Theresa M Im, Sara Y Tartof
Outcomes of adult patients in the intensive care unit with Pseudomonas aeruginosa pneumonia who received an active anti-pseudomonal β-lactam: Does "S" equal success in the presence of resistance to other anti-pseudomonal β-lactams? Pharmacotherapy 41 (8) (2021)
Monique R Bidell, Manjunath Amit P Pai, Thomas P Lodise
Use of Oral Tetracyclines in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia: A Literature Review on the Often-Overlooked Antibiotic Class. Antibiotics (Basel, Switzerland) 9 (12) (2020)
Thomas P Lodise, Sam Colman, Elizabeth Alexander, Daniel S Stein, David Fitts, Lisa Goldberg, Jennifer Schranz
Health-Related Quality of Life as Measured by the 12-Item Short-Form Survey Among Adults With Community-Acquired Bacterial Pneumonia who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials. Open forum infectious diseases 7 (6) (2020)
Nicholas J Mercuro, Thomas P Lodise, Rachel M Kenney, Berta Rezik, Raghavendra C Vemulapalli, Mariam J Costandi, Susan L Davis
Impact of unit-specific metrics and prescribing tools on a family medicine ward. Infection control and hospital epidemiology 41 (11) (2020)
Thomas P Lodise, Hemanth Kanakamedala, Wei-Chun Hsu, Bin Cai
Impact of Incremental Delays in Appropriate Therapy on the Outcomes of Hospitalized Adult Patients with Gram-negative Bloodstream Infections: "Every day matters". Pharmacotherapy 40 (9) (2020)
J Nicholas O'Donnell, Monique R Bidell, Thomas P Lodise
Approach to the Treatment of Patients with Serious Multidrug-Resistant Pseudomonas aeruginosa Infections. Pharmacotherapy 40 (9) (2020)
Nimish Patel, Nicholas Stornelli, Ryan J Sangiovanni, David B Huang, Thomas P Lodise
Effect of Vancomycin-Associated Acute Kidney Injury on Incidence of 30-Day Readmissions among Hospitalized Veterans Affairs Patients with Skin and Skin Structure Infections. Antimicrobial agents and chemotherapy 64 (10) (2020)
Thomas P Lodise, Michael Joseph Rybak
COVID-19: Important Therapy Considerations and Approaches in this Hour of Need. Pharmacotherapy 40 (5) (2020)
Michael Joseph Rybak, Jennifer Le, Thomas P Lodise, Donald P Levine, John S Bradley, Catherine Liu, Bruce A Mueller, Manjunath P Pai, Annie Wong-Beringer, John C Rotschafer, Keith A Rodvold, Holly D Maples, Benjamin M Lomaestro
Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy 40 (4) (2020)
Christopher M Bland, Manjunath Amit P Pai, Thomas P Lodise
Reappraisal of Contemporary Pharmacokinetic and Pharmacodynamic Principles for Informing Aminoglycoside Dosing. Pharmacotherapy 38 (12) (2019)
Monique R Bidell, Thomas P Lodise
Suboptimal Clinical Response Rates with Newer Antibiotics Among Patients with Moderate Renal Impairment: Review of the Literature and Potential Pharmacokinetic and Pharmacodynamic Considerations for Observed Findings. Pharmacotherapy 38 (12) (2018)